Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 5
2005 5
2006 13
2007 17
2008 20
2009 20
2010 21
2011 28
2012 42
2013 53
2014 50
2015 63
2016 51
2017 50
2018 73
2019 81
2020 119
2021 109
2022 123
2023 140
2024 142
2025 149
2026 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,260 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer: pathogenesis and treatments.
Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD. Xiong X, et al. Among authors: huang l. Signal Transduct Target Ther. 2025 Feb 19;10(1):49. doi: 10.1038/s41392-024-02108-4. Signal Transduct Target Ther. 2025. PMID: 39966355 Free PMC article. Review.
Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics.
Qin P, Chen H, Wang Y, Huang L, Huang K, Xiao G, Han C, Hu J, Lin D, Wan X, Zheng Y, Liu Y, Li G, Yang H, Ye S, Luo M, Fu Y, Xu H, Wen L, Guo Z, Shen X, Li Z, Wang C, Chen X, Wang L, Sun L, Ren D, Wu L, Wang J, Liu S, Lin H. Qin P, et al. Among authors: huang l. Cell Rep Med. 2023 Oct 17;4(10):101231. doi: 10.1016/j.xcrm.2023.101231. Cell Rep Med. 2023. PMID: 37852187 Free PMC article.
Algorithm for optimized mRNA design improves stability and immunogenicity.
Zhang H, Zhang L, Lin A, Xu C, Li Z, Liu K, Liu B, Ma X, Zhao F, Jiang H, Chen C, Shen H, Li H, Mathews DH, Zhang Y, Huang L. Zhang H, et al. Among authors: huang l. Nature. 2023 Sep;621(7978):396-403. doi: 10.1038/s41586-023-06127-z. Epub 2023 May 2. Nature. 2023. PMID: 37130545 Free PMC article.
Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.
Ye Z, Ai X, Yang K, Yang Z, Fei F, Liao X, Qiu Z, Gimple RC, Yuan H, Huang H, Gong Y, Xiao C, Yue J, Huang L, Saulnier O, Wang W, Zhang P, Dai L, Wang X, Wang X, Ahn YH, You C, Xu J, Wan X, Taylor MD, Zhao L, Rich JN, Zhou S. Ye Z, et al. Among authors: huang l. Cancer Discov. 2023 Apr 3;13(4):974-1001. doi: 10.1158/2159-8290.CD-22-0455. Cancer Discov. 2023. PMID: 36649564 Free PMC article.
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial.
Zeng Z, Luo S, Zhang H, Wu M, Ma D, Wang Q, Xie M, Xu Q, Ouyang J, Xiao Y, Song Y, Feng B, Xu Q, Wang Y, Zhang Y, Shi L, Ling L, Zhang X, Huang L, Yang Z, Peng J, Wu X, Ren D, Huang M, Lan P, Wang J, Tong W, Ren M, Liu H, Kang L; Chinese Transanal Endoscopic Surgery Collaborative (CTESC) Group. Zeng Z, et al. Among authors: huang l. JAMA. 2025 Mar 4;333(9):774-783. doi: 10.1001/jama.2024.24276. JAMA. 2025. PMID: 39847361 Free PMC article. Clinical Trial.
iMeta Conference 2025: Creating high-impact international journals.
Zhu Z, Zhang L, Yao X, Zeng M, Wang Y, Luo H, Zhou Y, Zhang T, Xun J, Bai D, Yang H, Xu S, Zhou Y, Gao Y, Xu J, Han W, Shen Z, Zhang B, Ma T, Wan XL, Ma C, Hui F, Bai H, Bai L, Bai Q, Bao Q, Cao G, Cao P, Cao Q, Chen H, Chen J, Chen J, Chen L, Chen T, Chen Y, Cui H, Dai S, Dai XJ, Dai X, Dang Y, Deng L, Deng Y, Ding X, Dong B, Dong L, Dou S, Du H, Fang Z, Feng X, Fu M, Gao Y, Gong W, Guo X, Han W, Hao Z, He ZG, Hu H, Hu H, Hu X, Huang L, Huang X, Huang X, Hui H, Jia D, Jiang A, Jiang D, Jiang K, Jiang D, Jin Y, Lai K, Li C, Li F, Li F, Li J, Li J, Li J, Li K, Li L, Li M, Li P, Li P, Li R, Li S, Li S, Li W, Li W, Li X, Li X, Li X, Liang Q, Liao X, Liu B, Liu C, Liu C, Liu D, Liu F, Liu J, Liu J, Liu S, Liu T, Liu W, Liu Y, Liu Y, Liu Y, Liu Y, Liu Y, Liu Z, Liu Z, Lu X, Luo X, Ma G, Meng J, Meng Y, Miao R, Miao L, Ni Y, Niu D, Niu T, Pan H, Qin G, Qiu T, Qiu Y, Qu H, Qu L, Ren N, Sun Q, Shang R, She P, Shen X, Shi B, Shu Y, Song J, Song W, Su Q, Sun Q, Sun Y, Sun Z, Tang B, Tang D, Tang H, Tao Y, Teng T, Tu Y, Wang C, Wang H, Wang Y, Wang C, Wang D, Wang G, Wang J, Wang K, Wang M, Wang S, Wang S, Wang X, Wang XC, Wang Y, Wang J, Wang Z, Wang W, Wei Y, Xu W, Wu F, Wu J, Wu S,… See abstract for full author list ➔ Zhu Z, et al. Among authors: huang l. Imeta. 2025 Oct 15;4(6):e70086. doi: 10.1002/imt2.70086. eCollection 2025 Dec. Imeta. 2025. PMID: 41472845 Free PMC article.
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
Huang L, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang HC, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, Jiang Z, Wang H, Lamour F, Song G, Curran M, Duan C, Lysbet de Haas S, Restuccia E, Shao Z. Huang L, et al. Nat Commun. 2024 Mar 9;15(1):2153. doi: 10.1038/s41467-024-45591-7. Nat Commun. 2024. PMID: 38461323 Free PMC article. Clinical Trial.
1,260 results